In 2023, industry is witnessing a renaissance in viral vector characterization. Spurred by widespread biopharma investment to engineer a new wave of novel capsids and faced with newly launched QbD frameworks by US Pharmacopeia and the FDA鈥檚 tightened guidance, increased vector complexity is creating a new era for advanced analytical technologies to ensure precision and accuracy.
In the wake of significant collaborations including Vector Bio and iBET鈥檚 for high-throughput characterization, and the likes of Vertex and BMS announcing their priority to build out their internal analytical competencies, the inaugural Viral Vector Characterization & Analytical Development Summit arrives to pave the foundation for teams to further optimize process development and accelerate vector scale-up with GMP compliance in mind.
Uniting Characterization, Analytical, Formulation, Quality, Engineering, CMC and Process leaders, this industry-led summit is your only for cross-learning opportunities across AAV鈥檚, LV鈥檚 & RV鈥檚 and more 鈥� so you can benchmark your work against rapid-analytical method development transforming your peers鈥� workflows, turnaround, and consistency.
Stay ahead of the curve, and join the likes of Ultragenyx, Kite Pharma, BioMarin, Neogene Therapeutics, Pfizer and many more for a 3-day jam packed agenda, set to tackle your biggest bottlenecks.
In the wake of significant collaborations including Vector Bio and iBET鈥檚 for high-throughput characterization, and the likes of Vertex and BMS announcing their priority to build out their internal analytical competencies, the inaugural Viral Vector Characterization & Analytical Development Summit arrives to pave the foundation for teams to further optimize process development and accelerate vector scale-up with GMP compliance in mind.
Uniting Characterization, Analytical, Formulation, Quality, Engineering, CMC and Process leaders, this industry-led summit is your only for cross-learning opportunities across AAV鈥檚, LV鈥檚 & RV鈥檚 and more 鈥� so you can benchmark your work against rapid-analytical method development transforming your peers鈥� workflows, turnaround, and consistency.
Stay ahead of the curve, and join the likes of Ultragenyx, Kite Pharma, BioMarin, Neogene Therapeutics, Pfizer and many more for a 3-day jam packed agenda, set to tackle your biggest bottlenecks.
